Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 219 member B is a human protein encoded by the FAM219B gene on chromosome 15[15][9]. It belongs to a group of uncharacterized proteins with sequence similarity, with no well-defined molecular function, biological process, or disease association and is conserved in multiple species[1][13][5]. There is currently no experimental evidence for its involvement in signal transduction, cell cycle regulation, immune response, or other common biological pathways. Its clinical and therapeutic significance remains uncharacterized, and it is not recognized as a conventional drug target, receptor, enzyme, or biomarker[14][9][15].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 219 member B (FAM219B).